Latest Omega Fund Management, LLC Stock Portfolio

Omega Fund Management, LLC Performance:

2024 Q3: -3.17%YTD: 15.15%2023: -31.76%

Performance for 2024 Q3 is -3.17%, and YTD is 15.15%, and 2023 is -31.76%.

About Omega Fund Management, LLC and 13F Hedge Fund Stock Holdings

Omega Fund Management, LLC is a hedge fund based in BOSTON, MA. On 12-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.4 Billions. In it's latest 13F Holdings report, Omega Fund Management, LLC reported an equity portfolio of $160 Millions as of 30 Sep, 2024.

The top stock holdings of Omega Fund Management, LLC are , NUVB, REPL. The fund has invested 35.1% of it's portfolio in BICARA THERAPEUTICS INC. and 18.7% of portfolio in NUVATION BIO.

The fund managers got completely rid off MORPHIC HOLDING (MORF) stocks. They significantly reduced their stock positions in NUVATION BIO (NUVB) and ALUMIS INC. Omega Fund Management, LLC opened new stock positions in BICARA THERAPEUTICS INC..

Omega Fund Management, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Omega Fund Management, LLC made a return of -3.17% in the last quarter. In trailing 12 months, it's portfolio return was -11.18%.

New Buys

Ticker	$ Bought
bicara therapeutics inc.	56,152,400

New stocks bought by Omega Fund Management, LLC

Additions

No additions were made to existing positions by Omega Fund Management, LLC

Reductions

Ticker	% Reduced
nuvation bio	-1.53
alumis inc	0.00

Omega Fund Management, LLC reduced stake in above stock

Sold off

Ticker	$ Sold
morphic holding	-5,445,950

Omega Fund Management, LLC got rid off the above stocks

Sector Distribution

Omega Fund Management, LLC has about 57.6% of it's holdings in Others sector.

Sector	%
Others	57.6
Healthcare	42.4

Market Cap. Distribution

Omega Fund Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
UNALLOCATED	57.6
SMALL-CAP	37.8
MICRO-CAP	4.6

Stocks belong to which Index?

About 40.2% of the stocks held by Omega Fund Management, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	59.8
RUSSELL 2000	40.2

Top 5 Winners (%)		%
IMUX	immunic inc	48.6 %
REPL	replimune group	21.8 %
IKNA	ikena oncology	4.8 %

Top 5 Winners ($)		$
REPL	replimune group	4.8 M
IMUX	immunic inc	1.0 M
IKNA	ikena oncology	0.2 M

Top 5 Losers (%)		%
SYRS	syros pharmaceuticals	-58.3 %
SANA	sana biotechnology, inc.	-23.8 %
NUVB	nuvation bio	-21.2 %

Top 5 Losers ($)		$
NUVB	nuvation bio	-8.2 M
SANA	sana biotechnology, inc.	-1.1 M
SYRS	syros pharmaceuticals	-0.8 M

Omega Fund Management, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Omega Fund Management, LLC

Omega Fund Management, LLC has 11 stocks in it's portfolio. NUVB proved to be the most loss making stock for the portfolio. REPL was the most profitable stock for Omega Fund Management, LLC last quarter.

Last Reported on: 14 Nov, 2024

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
IKNA	ikena oncology	2.43	2,249,120	3,890,980	unchanged	0.00

IMUX	immunic inc	1.84	1,788,160	2,950,460	unchanged	0.00

MORF	morphic holding	0.00	0.00	0.00	sold off	-100

NUVB	nuvation bio	18.71	13,072,300	29,935,700	reduced	-1.53

REPL	replimune group	16.86	2,461,320	26,976,100	unchanged	0.00

SANA	sana biotechnology, inc.	2.19	843,750	3,510,000	unchanged	0.00

SYRS	syros pharmaceuticals	0.34	251,270	540,231	unchanged	0.00

	bicara therapeutics inc.	35.09	2,204,650	56,152,400	new

	lexeo therapeutics	13.31	2,355,900	21,297,400	unchanged	0.00

	engene holdings inc.	4.44	1,076,360	7,103,960	unchanged	0.00

	alumis inc	4.36	653,223	6,976,420	reduced	0.00

	engene holdings inc.	0.42	321,502	675,154	unchanged	0.00